Treatments:Diabetes
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
<tr> | <tr> | ||
<td style="width:25%; vertical-align:top;border-width:1px;"> | <td style="width:25%; vertical-align:top;border-width:1px;"> | ||
| - | =====Insulin===== | + | =====[[Insulin]]===== |
*[[Lantus]] - Generic: [[Insulin glargine]] | *[[Lantus]] - Generic: [[Insulin glargine]] | ||
*[[NovoLog]] - Generic: [[Insulin aspart]] | *[[NovoLog]] - Generic: [[Insulin aspart]] | ||
Revision as of 12:06, 28 January 2024
Insulin
Dipeptidyl peptidase IV Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist
Glucagon-like peptide-1 (GLP-1) agonist
Mechanism is not completely understood
Inhibitors of the sodium glucose co-transporter-2 (SGLT-2) |
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
